Dow Down 0.92% Nasdaq Down 0.83%

Celsion Corp. (CLSN)

-NasdaqCM
2.54 Down 0.09(3.24%) 4:00PM EDT
Prev Close:2.63
Open:2.60
Bid:N/A
Ask:2.67 x 3000
1y Target Est:8.00
Beta:1.85
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:2.52 - 2.70
52wk Range:2.38 - 5.90
Volume:34,992
Avg Vol (3m):100,383
Market Cap:50.69M
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLSN

Comparison

Symbol% ChgMkt Cap
CLSNDown 3.24%50.69M
BSDMUp 1.81%21.43M
DCTHDown 2.29%16.15M
MMSIUp 0.31%552.45M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):104.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.33
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback